Previous 10 | Next 10 |
BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, extending expected cash runway into 2026 CLEVELAND, May 15, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
2024-05-03 08:14:19 ET More on Abeona Therapeutics Buying The Dip In Abeona Therapeutics After The Recent Manufacturing-Related CRL Abeona Therapeutics Tanks On CRL From The FDA, But All Hope Is Not Lost Read the full article on Seeking Alpha For further deta...
CLEVELAND, May 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) (“Abeona” or the “Company”) today announced the pricing of an underwritten offering of 12,285,056 shares of its common stock and, in lieu of common stock, pre-funded warrants to purchas...
2024-05-02 17:50:00 ET Summary Abeona Therapeutics is a gene therapy company with a lead product candidate, Pz-cel, for recessive epidermolysis bullosa, or RDEB. Pz-cel has shown higher efficacy than the competition in treating larger skin lesions in RDEB. Despite receiving a ...
2024-04-23 17:20:16 ET Summary Abeona Therapeutics Inc. stock dropped by over half after receiving a Complete Response Letter from the FDA regarding its Biologics License Application for pz-cel. The FDA identified manufacturing issues that need to be resolved, delaying the potenti...
A look at the top 10 most actives in the United States Cyngn Inc. (CYN) fell 5.8% to $0.114 on volume of 321,909,962 shares Pineapple Energy Inc. (PEGY) rose 23.6% to $0.0566 on volume of 180,092,924 shares NewGenIvf Group Limited (NIVF) rose 74.2% to $2.23 on volume of 136,563,105 shares...
2024-04-23 13:16:54 ET More on Mid-day movers & stocks. Kopin Corporation (KOPN) Q4 2023 Earnings Call Transcript Cemtrex, Inc. (CETX) Q1 2024 Earnings Call Transcript Kopin GAAP EPS of -$0.06 misses by $0.03, revenue of $8.6M misses by $0.43M Cemtrex GAA...
A look at the top 10 most actives in the United States Cyngn Inc. (CYN) rose 90.2% to $0.2302 on volume of 145,513,222 shares Pineapple Energy Inc. (PEGY) rose 47.8% to $0.0677 on volume of 101,675,442 shares AGBA Group Holding Limited (AGBA) rose 8.7% to $2.7186 on volume of 17,457,670 s...
2024-04-23 08:17:15 ET More on pre-market losers & stocks. Affirm: Acceleration Across The Board Affirm Holdings: Hard To Win Against Block, PayPal And Klarna, Amid Substantial Losses Affirm: Stunning Acceleration In Growth And Margin Expansion (Rating Upgrade) ...
News, Short Squeeze, Breakout and More Instantly...
Abeona Therapeutics Inc. Company Name:
ABEO Stock Symbol:
NASDAQ Market:
Abeona Therapeutics Inc. Website:
CLEVELAND and LONDON, July 11, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a cell and gene therapy company with proprietary adeno-associated virus (AAV)-based capsids, and Beacon Therapeutics, an ophthalmic gene therapy company and Syncona portfolio company, today announced ...
CLEVELAND, July 08, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Abeona’s Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., and Chief Commercial Officer, Madhav Vasanthavada, Ph.D., M.B.A., will participate in a virtual fireside chat at the Sti...
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ABEO on July 3, 2024 06:07AM ET. ABEO was trading at $4.12 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...